Drug Repositioning Study on the Antiemetic Efficacy of Anamorelin for Cisplatin-Induced Nausea and Vomiting in Rats-Reference-Cited by-同舟云学术

Drug Repositioning Study on the Antiemetic Efficacy of Anamorelin for Cisplatin-Induced Nausea and Vomiting in Rats

Published:2024 Issue:1 Volume:7 Page:1-6
ISSN:2434-432X
Container-title:BPB Reports
language:en
Short-container-title:

Author:

Nishino Haruto¹,Kawazoe Hitoshi¹,Sekiguchi Mayu¹,Jibiki Aya¹,Yokoyama Yuta¹,Suzuki Sayo¹,Nakamura Tomonori²

Affiliation:

1. Division of Pharmaceutical Care Sciences, Center for Social Pharmacy and Pharmaceutical Care Sciences, Keio University Faculty of Pharmacy

2. Division of Pharmaceutical Care Sciences, Keio University Graduate School of Pharmaceutical Sciences

Publisher

Pharmaceutical Society of Japan

Subject

Industrial and Manufacturing Engineering

Link

https://www.jstage.jst.go.jp/article/bpbreports/7/1/7_1/_pdf

Reference26 articles.

1. 1) Ito Y, Tsuda T, Minatogawa H, Kano S, Sakamaki K, Ando M, Tsugawa K, Kojima Y, Furuya N, Matsuzaki K, Fukuda M, Sugae S, Ohta I, Arioka H, Tokuda Y, Narui K, Tsuboya A, Suda T, Morita S, Boku N, Yamanaka T, Nakajima TE. Placebo-controlled, double-blinded phase III study comparing dexamethasone on Day 1 with dexamethasone on Days 1 to 3 with combined Neurokinin-1 receptor antagonist and palonosetron in high-emetogenic chemotherapy. J. Clin. Oncol., 36, 1000–1006 (2018).

2. 2) Hesketh PJ, Kris MG, Basch E, Bohlke K, Barbour SY, Clark-Snow RA, Danso MA, Dennis K, Dupuis LL, Dusetzina SB, Eng C, Feyer PC, Jordan K, Noonan K, Sparacio D, Lyman GH. Antiemetics: ASCO guideline update. J. Clin. Oncol., 38, 2782–2797 (2020).

3. 3) Aogi K, Takeuchi H, Saeki T, Aiba K, Tamura K, Iino K, Imamura CK, Okita K, Kagami Y, Tanaka R, Nakagawa K, Fujii H, Boku N, Wada M, Akechi T, Iihara H, Ohtani S, Okuyama A, Ozawa K, Kim YI, Sasaki H, Shima Y, Takeda M, Nagasaki E, Nishidate T, Higashi T, Hirata K. Optimizing antiemetic treatment for chemotherapy-induced nausea and vomiting in Japan: Update summary of the 2015 Japan Society of Clinical Oncology Clinical Practice Guidelines for Antiemesis. Int. J. Clin. Oncol., 26, 1–17 (2021).

4. 4) National Comprehensive Cancer Network. Antiemesis version 1.2024. Available at: https://www.nccn.org/professionals/physician_gls/pdf/antiemesis.pdf (2024), accessed 24 December 2023.

5. 5) Suzuki K, Yamanaka T, Hashimoto H, Shimada Y, Arata K, Matsui R, Goto K, Takiguchi T, Ohyanagi F, Kogure Y, Nogami N, Nakao M, Takeda K, Azuma K, Nagase S, Hayashi T, Fujiwara K, Shimada T, Seki N, Yamamoto N. Randomized, double-blind, phase III trial of palonosetron versus granisetron in the triplet regimen for preventing chemotherapy-induced nausea and vomiting after highly emetogenic chemotherapy: TRIPLE study. Ann. Oncol., 27, 1601–1606 (2016).